Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Grosso

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Journal of Translational Medicine|April 6, 2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerSatoshi Wada, Christopher M Jackson, Kiyoshi Yoshimura, et al.
Science (New York, N.Y.)|August 22, 2009
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cellsFan Pan, Hong Yu, Eric V Dang, et al.
The Journal of Clinical Investigation|October 13, 2007
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systemsJoseph F Grosso, Cristin C Kelleher, Timothy J Harris, et al.
British Journal of Cancer|June 12, 2014
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyG L Ceresoli, F Grosso, P A Zucali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunityTimothy J Harris, Joseph F Grosso, Hung-Rong Yen, et al.
Molecular Immunology|March 16, 2010
A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cellsDerese Getnet, Joseph F Grosso, Monica V Goldberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2018
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over timeG Pasello, G Zago, F Lunardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cellsDerese Getnet, Charles H Maris, Edward L Hipkiss, et al.
Oncoimmunology|January 4, 2018
Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor modelsKatherine E Lewis, Mark J Selby, Gregg Masters, et al.
Cancer|June 14, 2017
Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissuesRobbie G Majzner, Jason S Simon, Joseph F Grosso, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Journal of Translational Medicine|April 6, 2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerSatoshi Wada, Christopher M Jackson, Kiyoshi Yoshimura, et al.
Science (New York, N.Y.)|August 22, 2009
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cellsFan Pan, Hong Yu, Eric V Dang, et al.
The Journal of Clinical Investigation|October 13, 2007
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systemsJoseph F Grosso, Cristin C Kelleher, Timothy J Harris, et al.
British Journal of Cancer|June 12, 2014
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyG L Ceresoli, F Grosso, P A Zucali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunityTimothy J Harris, Joseph F Grosso, Hung-Rong Yen, et al.
Molecular Immunology|March 16, 2010
A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cellsDerese Getnet, Joseph F Grosso, Monica V Goldberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2018
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over timeG Pasello, G Zago, F Lunardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cellsDerese Getnet, Charles H Maris, Edward L Hipkiss, et al.
Oncoimmunology|January 4, 2018
Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor modelsKatherine E Lewis, Mark J Selby, Gregg Masters, et al.
Cancer|June 14, 2017
Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissuesRobbie G Majzner, Jason S Simon, Joseph F Grosso, et al.
Pageof 10